- Home
- SEED vs CYCN Comparison
SEED vs CYCN Comparison
Compare SEED & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEED
- CYCN
- Stock Information
- Founded
- SEED 1997
- CYCN 2018
- Country
- SEED China
- CYCN United States
- Employees
- SEED N/A
- CYCN N/A
- Industry
- SEED Farming/Seeds/Milling
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- SEED Consumer Staples
- CYCN Health Care
- Exchange
- SEED Nasdaq
- CYCN Nasdaq
- Market Cap
- SEED 8.6M
- CYCN 8.0M
- IPO Year
- SEED N/A
- CYCN N/A
- Fundamental
- Price
- SEED $1.16
- CYCN $2.33
- Analyst Decision
- SEED
- CYCN
- Analyst Count
- SEED 0
- CYCN 0
- Target Price
- SEED N/A
- CYCN N/A
- AVG Volume (30 Days)
- SEED 93.0K
- CYCN 24.8K
- Earning Date
- SEED 06-26-2025
- CYCN 11-13-2025
- Dividend Yield
- SEED N/A
- CYCN N/A
- EPS Growth
- SEED N/A
- CYCN N/A
- EPS
- SEED N/A
- CYCN N/A
- Revenue
- SEED $12,910,081.00
- CYCN $2,174,000.00
- Revenue This Year
- SEED N/A
- CYCN N/A
- Revenue Next Year
- SEED N/A
- CYCN N/A
- P/E Ratio
- SEED N/A
- CYCN N/A
- Revenue Growth
- SEED N/A
- CYCN N/A
- 52 Week Low
- SEED $0.74
- CYCN $1.27
- 52 Week High
- SEED $3.59
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- SEED 55.55
- CYCN 45.15
- Support Level
- SEED $1.00
- CYCN $2.13
- Resistance Level
- SEED $1.20
- CYCN $2.59
- Average True Range (ATR)
- SEED 0.10
- CYCN 0.21
- MACD
- SEED 0.00
- CYCN 0.01
- Stochastic Oscillator
- SEED 78.12
- CYCN 32.79
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.